Gero A M, O'Sullivan W J, Wright I G, Mahoney D F
Aust J Exp Biol Med Sci. 1983 Apr;61 (Pt 2):239-43. doi: 10.1038/icb.1983.22.
All six enzymes of de novo pyrimidine biosynthesis leading to the formation of UMP have been demonstrated in whole homogenates from two bovine Babesia species, B. bovis and B. bigemina. The specific activities of the respective enzymes were of the same order of magnitude as observed for the related parasite, Plasmodium berghei. The results indicate that both these parasites have the potential of obtaining their pyrimidine requirements by de novo synthesis. Subcellular fractionation established that dihydroorotate dehydrogenase, the fourth enzyme of the pathway, was of a particulate nature. Mammalian respiratory chain inhibitors and ubiquinone analogues caused inhibition of the Babesia dihydroorotate dehydrogenase. As observed for other eukaryotic systems, the dehydrogenase appears to be linked to a respiratory chain via ubiquinone.
导致UMP形成的从头嘧啶生物合成途径中的所有六种酶,已在两种牛巴贝斯虫(牛巴贝斯虫和双芽巴贝斯虫)的全匀浆中得到证实。各酶的比活性与相关寄生虫伯氏疟原虫所观察到的处于同一数量级。结果表明,这两种寄生虫都有通过从头合成来满足其嘧啶需求的潜力。亚细胞分级分离表明,该途径的第四种酶二氢乳清酸脱氢酶具有颗粒性质。哺乳动物呼吸链抑制剂和泛醌类似物会抑制巴贝斯虫的二氢乳清酸脱氢酶。正如在其他真核系统中所观察到的,该脱氢酶似乎通过泛醌与呼吸链相连。